{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T07:14:36Z","timestamp":1793171676236,"version":"4.5.0"},"reference-count":50,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2016,9,9]],"date-time":"2016-09-09T00:00:00Z","timestamp":1473379200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009708","name":"Novo Nordisk fonden","doi-asserted-by":"crossref","award":["53101003"],"award-info":[{"award-number":["53101003"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0162733","type":"journal-article","created":{"date-parts":[[2016,9,9]],"date-time":"2016-09-09T18:07:12Z","timestamp":1473444432000},"page":"e0162733","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":36,"title":["Oral Delivery of Pentameric Glucagon-Like Peptide-1 by Recombinant Lactobacillus in Diabetic Rats"],"prefix":"10.1371","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6294-8241","authenticated-orcid":false,"given":"Yin","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kasper","family":"Krogh-Andersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Pelletier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harold","family":"Marcotte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claes-G\u00f6ran","family":"\u00d6stenson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lennart","family":"Hammarstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2016,9,9]]},"reference":[{"key":"ref1","article-title":"Robbins and Cotran pathologic basis of disease","author":"V Kumar","year":"2005"},{"issue":"3","key":"ref2","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s001250051165","article-title":"Is glucagon-like peptide 1 an incretin hormone?","volume":"42","author":"MA Nauck","year":"1999","journal-title":"Diabetologia"},{"issue":"40","key":"ref3","doi-asserted-by":"crossref","first-page":"16199","DOI":"10.1073\/pnas.1306799110","article-title":"Glucagon-like peptide 1 receptor induced suppression of food intake, and body weight is mediated by central IL-1 and IL-6","volume":"110","author":"R Shirazi","year":"2013","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"4","key":"ref4","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1152\/physrev.00034.2006","article-title":"The physiology of glucagon-like peptide 1","volume":"87","author":"JJ Holst","year":"2007","journal-title":"Physiological reviews"},{"issue":"1\u20132","key":"ref5","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ejps.2006.01.003","article-title":"GLP-1 based therapy for type 2 diabetes","volume":"28","author":"DK Arulmozhi","year":"2006","journal-title":"European journal of pharmaceutical sciences: official journal of the European Federation for Pharmaceutical Sciences"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1464-5491.2006.01833e.x","article-title":"Therapeutic intervention in the GLP-1 pathway in Type 2 diabetes","volume":"23","author":"JC Levy","year":"2006","journal-title":"Diabetic Medicine"},{"issue":"10","key":"ref7","doi-asserted-by":"crossref","first-page":"3703","DOI":"10.1210\/jc.2007-2109","article-title":"Incretin-based therapies in type 2 diabetes mellitus","volume":"93","author":"CW Chia","year":"2008","journal-title":"The Journal of clinical endocrinology and metabolism"},{"key":"ref8","doi-asserted-by":"crossref","DOI":"10.1159\/isbn.978-3-318-01934-6","article-title":"The Insulinotropic Gut Hormone Glucagon-like Peptide-1","author":"HC Fehmann","year":"1997"},{"issue":"6","key":"ref9","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1530\/eje.0.1460863","article-title":"The short half-life of glucagon-like peptide-1 in plasma does not reflect its long-lasting beneficial effects","volume":"146","author":"H Hui","year":"2002","journal-title":"European journal of endocrinology \/ European Federation of Endocrine Societies"},{"issue":"3","key":"ref10","first-page":"281","article-title":"Exenatide (Byetta) as a novel treatment option for type 2 diabetes mellitus","volume":"19","author":"A Bond","year":"2006","journal-title":"Proceedings"},{"issue":"Suppl 2","key":"ref11","doi-asserted-by":"crossref","first-page":"S279","DOI":"10.2337\/dc11-s231","article-title":"Long-acting glucagon-like peptide 1 receptor agonists: a review of their efficacy and tolerability","volume":"34","author":"AJ Garber","year":"2011","journal-title":"Diabetes care"},{"issue":"2","key":"ref12","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/S0026-0495(99)90043-4","article-title":"Long-lasting antidiabetic effect of a dipeptidyl peptidase IV-resistant analog of glucagon-like peptide-1","volume":"48","author":"R Burcelin","year":"1999","journal-title":"Metabolism: clinical and experimental"},{"issue":"6","key":"ref13","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1038\/clpt.2009.159","article-title":"Orally Administered Glucagon-Like Peptide-1 Affects Glucose Homeostasis Following an Oral Glucose Tolerance Test in Healthy Male Subjects","volume":"86","author":"RE Steinert","year":"2009","journal-title":"Clinical Pharmacology & Therapeutics"},{"issue":"6","key":"ref14","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1177\/193229681200600630","article-title":"Oral delivery of glucagon-like peptide-1 and analogs: alternatives for diabetes control?","volume":"6","author":"F Araujo","year":"2012","journal-title":"Journal of diabetes science and technology"},{"issue":"3","key":"ref15","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.ejpb.2007.07.009","article-title":"Improved peroral delivery of glucagon-like peptide-1 by site-specific biotin modification: design, preparation, and biological evaluation","volume":"68","author":"YS Youn","year":"2008","journal-title":"European journal of pharmaceutics and biopharmaceutics: official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik eV"},{"issue":"1","key":"ref16","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1021\/bc700292v","article-title":"Preparation, characterization, and application of biotinylated and biotin-PEGylated glucagon-like peptide-1 analogues for enhanced oral delivery","volume":"19","author":"SY Chae","year":"2008","journal-title":"Bioconjugate chemistry"},{"issue":"10","key":"ref17","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1007\/s001250051529","article-title":"Oral delivery of glucagon-like peptide-1 in a modified polymer preparation normalizes basal glycaemia in diabetic db\/db mice","volume":"43","author":"JW Joseph","year":"2000","journal-title":"Diabetologia"},{"issue":"10","key":"ref18","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1016\/j.biomaterials.2010.12.044","article-title":"The glucose-lowering potential of exendin-4 orally delivered via a pH-sensitive nanoparticle vehicle and effects on subsequent insulin secretion in vivo","volume":"32","author":"HN Nguyen","year":"2011","journal-title":"Biomaterials"},{"issue":"5","key":"ref19","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/nrmicro1840","article-title":"Mucosal delivery of therapeutic and prophylactic molecules using lactic acid bacteria","volume":"6","author":"JM Wells","year":"2008","journal-title":"Nature reviews Microbiology"},{"issue":"6","key":"ref20","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1271\/bbb.67.1421","article-title":"Antidiabetic effect of Lactobacillus GG in streptozotocin-induced diabetic rats","volume":"67","author":"M Tabuchi","year":"2003","journal-title":"Bioscience, biotechnology, and biochemistry"},{"issue":"5","key":"ref21","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1111\/j.1365-2672.2009.04350.x","article-title":"Effect of Lactobacillus gasseri BNR17 on blood glucose levels and body weight in a mouse model of type 2 diabetes","volume":"107","author":"SI Yun","year":"2009","journal-title":"Journal of applied microbiology"},{"issue":"5","key":"ref22","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.2337\/db14-0635","article-title":"Engineered commensal bacteria reprogram intestinal cells into glucose-responsive insulin-secreting cells for the treatment of diabetes","volume":"64","author":"FF Duan","year":"2015","journal-title":"Diabetes"},{"issue":"4","key":"ref23","doi-asserted-by":"crossref","first-page":"e96409","DOI":"10.1371\/journal.pone.0096409","article-title":"Co-expression of anti-rotavirus proteins (llama VHH antibody fragments) in Lactobacillus: development and functionality of vectors containing two expression cassettes in tandem","volume":"9","author":"G Gunaydin","year":"2014","journal-title":"PloS one"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/1472-6750-11-126","article-title":"In situ gastrointestinal protection against anthrax edema toxin by single-chain antibody fragment producing lactobacilli","volume":"11","author":"KK Andersen","year":"2011","journal-title":"BMC Biotechnol"},{"issue":"10","key":"ref25","doi-asserted-by":"crossref","first-page":"2647","DOI":"10.1128\/JB.00076-10","article-title":"Complete genome sequence of the probiotic Lactobacillus casei strain BL23","volume":"192","author":"A Maze","year":"2010","journal-title":"Journal of bacteriology"},{"issue":"Pt 1","key":"ref26","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1099\/ijs.0.02325-0","article-title":"Significant differences between Lactobacillus casei subsp. casei ATCC 393T and a commonly used plasmid-cured derivative revealed by a polyphasic study","volume":"53","author":"E Acedo-Felix","year":"2003","journal-title":"International journal of systematic and evolutionary microbiology"},{"issue":"6","key":"ref27","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.1128\/AEM.02690-10","article-title":"Integrative expression system for delivery of antibody fragments by lactobacilli","volume":"77","author":"MC Martin","year":"2011","journal-title":"Applied and environmental microbiology"},{"issue":"7","key":"ref28","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1038\/nbt0702-702","article-title":"In situ delivery of passive immunity by lactobacilli producing single-chain antibodies","volume":"20","author":"C Kruger","year":"2002","journal-title":"Nature biotechnology"},{"issue":"2","key":"ref29","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/j.1365-2672.2005.02786.x","article-title":"Expression of single-chain antibody against RgpA protease of Porphyromonas gingivalis in Lactobacillus","volume":"100","author":"H Marcotte","year":"2006","journal-title":"Journal of applied microbiology"},{"issue":"7","key":"ref30","doi-asserted-by":"crossref","first-page":"4339","DOI":"10.1073\/pnas.78.7.4339","article-title":"Insulin synthesis in a clonal cell line of simian virus 40-transformed hamster pancreatic beta cells","volume":"78","author":"RF Santerre","year":"1981","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"Suppl 2","key":"ref31","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/j.1463-1326.2007.00787.x","article-title":"Islet gene expression and function in type 2 diabetes; studies in the Goto-Kakizaki rat and humans","volume":"9","author":"CG Ostenson","year":"2007","journal-title":"Diabetes, obesity & metabolism"},{"issue":"2\u20133","key":"ref32","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0303-7207(86)90150-4","article-title":"Differences in long-term effects of L-glutamine and D-glucose on insulin release from rat pancreatic islets","volume":"45","author":"CG Ostenson","year":"1986","journal-title":"Molecular and cellular endocrinology"},{"issue":"10","key":"ref33","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1210\/jcem-25-10-1375","article-title":"Coated charcoal immunoassay of insulin","volume":"25","author":"V Herbert","year":"1965","journal-title":"The Journal of clinical endocrinology and metabolism"},{"issue":"2","key":"ref34","first-page":"131","article-title":"Herbal extract of gynostemma pentaphyllum decreases hepatic glucose output in type 2 diabetic goto-kakizaki rats","volume":"7","author":"K Yassin","year":"2011","journal-title":"International journal of biomedical science: IJBS"},{"key":"ref35","article-title":"ARA290 improves insulin release and glucose tolerance in type 2 diabetic GK rats","author":"C Muller","year":"2015","journal-title":"Molecular medicine (Cambridge, Mass)"},{"issue":"3","key":"ref36","doi-asserted-by":"crossref","first-page":"E504","DOI":"10.1152\/ajpendo.00099.2005","article-title":"Initially more rapid small intestinal glucose delivery increases plasma insulin, GIP, and GLP-1 but does not improve overall glycemia in healthy subjects","volume":"289","author":"R Chaikomin","year":"2005","journal-title":"American journal of physiology Endocrinology and metabolism"},{"issue":"1\u20133","key":"ref37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.regpep.2007.09.032","article-title":"Transient, early release of glucagon-like peptide-1 during low rates of intraduodenal glucose delivery","volume":"146","author":"P Kuo","year":"2008","journal-title":"Regulatory peptides"},{"issue":"6","key":"ref38","doi-asserted-by":"crossref","first-page":"3109","DOI":"10.1210\/endo-125-6-3109","article-title":"Comparison of the effects of various C-terminal and N-terminal fragment peptides of glucagon-like peptide-1 on insulin and glucagon release from the isolated perfused rat pancreas","volume":"125","author":"S Suzuki","year":"1989","journal-title":"Endocrinology"},{"issue":"1","key":"ref39","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1476-5381.2011.01687.x","article-title":"The structure and function of the glucagon-like peptide-1 receptor and its ligands","volume":"166","author":"D Donnelly","year":"2012","journal-title":"British journal of pharmacology"},{"issue":"10","key":"ref40","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/nmeth.1701","article-title":"SignalP 4.0: discriminating signal peptides from transmembrane regions","volume":"8","author":"TN Petersen","year":"2011","journal-title":"Nature methods"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1186\/1471-2164-10-425","article-title":"Genome-wide analysis of signal peptide functionality in Lactobacillus plantarum WCFS1","volume":"10","author":"G Mathiesen","year":"2009","journal-title":"BMC genomics"},{"issue":"5","key":"ref42","doi-asserted-by":"crossref","first-page":"387","DOI":"10.2174\/15733998113099990069","article-title":"Goto-Kakizaki rats: its suitability as non-obese diabetic animal model for spontaneous type 2 diabetes mellitus","volume":"9","author":"MS Akash","year":"2013","journal-title":"Current diabetes reviews"},{"issue":"12","key":"ref43","doi-asserted-by":"crossref","first-page":"3404","DOI":"10.1007\/s11095-014-1430-3","article-title":"Oral delivery of glucagon like peptide-1 by a recombinant Lactococcus lactis","volume":"31","author":"P Agarwal","year":"2014","journal-title":"Pharmaceutical research"},{"issue":"7","key":"ref44","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/nbt840","article-title":"Biological containment of genetically modified Lactococcus lactis for intestinal delivery of human interleukin 10","volume":"21","author":"L Steidler","year":"2003","journal-title":"Nature biotechnology"},{"issue":"5483","key":"ref45","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1126\/science.289.5483.1352","article-title":"Treatment of murine colitis by Lactococcus lactis secreting interleukin-10","volume":"289","author":"L Steidler","year":"2000","journal-title":"Science"},{"issue":"3","key":"ref46","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1111\/j.1365-2672.2010.04922.x","article-title":"Beneficial effect of oral administration of Lactobacillus casei strain Shirota on insulin resistance in diet-induced obesity mice","volume":"110","author":"E Naito","year":"2011","journal-title":"Journal of applied microbiology"},{"issue":"1","key":"ref47","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1743-7075-10-35","article-title":"Oral administration of Lactobacillus reuteri GMNL-263 improves insulin resistance and ameliorates hepatic steatosis in high fructose-fed rats","volume":"10","author":"FC Hsieh","year":"2013","journal-title":"Nutrition & metabolism"},{"issue":"4","key":"ref48","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1017\/S0007114513002791","article-title":"Oral Lactobacillus reuteri GMN-32 treatment reduces blood glucose concentrations and promotes cardiac function in rats with streptozotocin-induced diabetes mellitus","volume":"111","author":"CH Lin","year":"2014","journal-title":"The British journal of nutrition"},{"issue":"10","key":"ref49","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.2337\/dc14-2690","article-title":"Intake of Lactobacillus reuteri Improves Incretin and Insulin Secretion in Glucose-Tolerant Humans: A Proof of Concept","volume":"38","author":"MC Simon","year":"2015","journal-title":"Diabetes care"},{"issue":"2","key":"ref50","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/dmrr.2376","article-title":"Probiotics as potential biotherapeutics in the management of type 2 diabetes\u2014prospects and perspectives","volume":"29","author":"H Panwar","year":"2013","journal-title":"Diabetes\/metabolism research and reviews"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0162733","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T04:56:20Z","timestamp":1589691380000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0162733"}},"subtitle":[],"editor":[{"given":"Wanli W.","family":"Smith","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,9,9]]},"references-count":50,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2016,9,9]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0162733","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,9]]}}}